REDUCEDT+30
Oramed Pharmaceuticals Inc · NASDAQ
−30,000 sh · $135.3K
Filed 2 Oct 2026SEC Form 4view source
- ACQUIREDT+30
Oramed Pharmaceuticals Inc · NASDAQ
+75,455 sh
Filed 25 Sept 2026SEC Form 4view source - ACQUIREDT+30
Oramed Pharmaceuticals Inc · NASDAQ
+209,291 sh
Filed 25 Sept 2026SEC Form 4view source